The current study investigated the CYP4Z1 and CYP1B1 expressions across a panel of different types of bladder cancer to confirm the hypothesis that CYP4Z1and CYP1B1 expressions may present novel opportunities for the development of new treatments for bladder cancer. This evidence concerns the gene CYP1B1 and urinary bladder carcinoma.